Rick O’Brien

3.3k citations
11 papers · 2.5k · 2 hit papers · h-index 11

Impact in

Papers in

Rick O’Brien

11 papers receiving 2.4k citations

Rick O’Brien's Hit Papers

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis 2016 · 1.1k citations
1.1k0+6+12Years since publication2505007501k

Peers

Rick O’Brien
Comparison fields: 5 of 108
  • Infectious Diseases 1.5k
  • Applied Microbiology and Biotechnology 31
  • Parasitology 85
  • Pharmacology 98
  • Virology 34
Replace Martin J Dedicoat with:
Martin J Dedicoat United Kingdom
Miguel Santín Spain
Cédric Arvieux France
María Velasco Spain
Asda Vibhagool Thailand
Silvia Garazzino Italy
Hee‐Chang Jang South Korea
Ploenchan Chetchotisakd Thailand
John Z. Metcalfe United States
Ronald A. Greenfield United States
Rick O’Brien relative to Martin J Dedicoat United Kingdom Martin J Dedicoat's profile →
Citations per field
00.5×2×3.1×
Martin J Dedicoat · 1×
Citations per year

Countries citing papers authored by Rick O’Brien

Since Specialization
Citations

This map shows the geographic impact of Rick O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick O’Brien more than expected).

Fields of papers citing papers by Rick O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick O’Brien. The network helps show where Rick O’Brien may publish in the future.

Co-authors

The 25 scholars most cited alongside Rick O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rick O’Brien Line = papers co-authored together Rick O’Brien links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Hit paper breakdown →
20161066
2
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
Hit paper breakdown →
2007460
3 2006389
4 2016254
5 2010115
6 2006107
7 200948
8 201439
9 200732
10 201322
11 200816

About Rick O’Brien

Rick O’Brien is a scholar working on Clinical Biochemistry, Infectious Diseases, Physiology, Biomedical Engineering and Nuclear Energy and Engineering, having authored 11 papers that have together received 2.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Biosensors and Analytical Detection (5 papers), Clinical Laboratory Practices and Quality Control (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Applied Microbiology and Biotechnology (31 citations), Parasitology (85 citations), Pharmacology (98 citations) and Virology (34 citations). Rick O’Brien has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Paul P. Nunn, Haileyesus Getahun, Nivedita Sriram, Precious Matsoso, Rosanna Wai Wan Peeling, Jane A. Cunningham, Mark D. Perkins, Shabir Banoo, Andy Ramsay and David C. W. Mabey. Their work appears in journals such as Nature Reviews Microbiology, PLoS ONE, Clinical Infectious Diseases and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact